Skip to content

The development of a quality of life instrument specific to autoimmune bullous disease

The development of a quality of life instrument specific to autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life instrument (ABQOL)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12612000750886
Enrollment
70
Registered
2012-07-13
Start date
2007-05-05
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this project is to develop a quality of life instrument specific to autoimmune bullous disease. Patients with clinically and histologically diagnose autoimmune bullous disease will be recruited and interviewed regarding the ways their disease affects their quality of life. Based on these responses, a pilot questionnaire will be developed and given to 70 patients. Statistical analysis will then be performed based on the results of these questionnaires to determine whether the instrument is statistically sound or not. If it is validated, the instrument can then be used as a tool to measure quality of life in patients with autoimmune blistering skin diseases.

Interventions

Patients with clinically and histologically diagnosed autoimmune bullous disease will participate in the development of a disease specific quality of life instrument. They will express the ways in which their blistering diseases affects their quality of life. Based on these responses, a pilot questionnaire will be developed. Patients will then be asked to complete the pilot questionnaire once. Statistical analyses will be completed on the responses to determine whether the questionnaire is a sta

Patients with clinically and histologically diagnosed autoimmune bullous disease will participate in the development of a disease specific quality of life instrument. They will express the ways in which their blistering diseases affects their quality of life. Based on these responses, a pilot questionnaire will be developed. Patients will then be asked to complete the pilot questionnaire once. Statistical analyses will be completed on the responses to determine whether the questionnaire is a statistically sound.

Sponsors

Australasian Blistering Diseases Foundation
Lead SponsorCharities/Societies/Foundations

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Clinically and histologically diagnosed autoimmune bullous disease

Exclusion criteria

Limited fluency in English

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 10, 2026